Secondary care / Projects

First Programme of Community action in the field of public health (2003-2008)
Senior Drug Dependents and Care Structures [SDDCare]
The project aims to:
create a knowledge base on senior drug dependents in different age brackets and by gender and on their care and treatment needs;
elaborate practical implementation tools in form...
The project aims to:
create a knowledge base on senior drug dependents in different age brackets and by gender and on their care and treatment needs;
elaborate practical implementation tools in form of guidelines for the implementation of outpatient (non-residential) and residential care structures and offers which are in line with gender mainstreaming principles.
Start date: 01/01/2008 - End date: 01/07/2010

Call: Health Determinants (Hd 2006)
Topic: Secondary care
Second Programme of Community action in the Field of Health 2008-2013
ALzheimer COoperative Valuation in Europe [ALCOVE]
The JA will be contribute to public health programmes in Europe and develop Alzheimers disease (AD) and dementia prevention and care models in different European countries. The aim is to contribute to...
The JA will be contribute to public health programmes in Europe and develop Alzheimers disease (AD) and dementia prevention and care models in different European countries. The aim is to contribute to improvements in health by supporting and facilitating quality and efficiency of public health and healthcare policies and interventions. Synergy and avoidance of duplication with other health and research programs will be ensured.
The aim is to build a sustainable European platform. The objectives of ALCOVE are to accomplish the following during the 2 year project duration:
1. Establish a European statement on Alzheimer`s disease: Propose a synthesis regarding AD information and practices in Europe which could be the basis for further implementation at the European level
2. Ability of the JA to support the implementation of good practices in the field of risk prevention with measured results for patients: a focus on the overuse of psychotropics.
Start date: 01/04/2011 - End date: 01/04/2013

Call: Promote Health (Hp-2010)
Topic: Secondary care
3rd Health Programme (2014-2020)
Promoting Implementation of Recommendations on Policy, Information and Data for Rare Diseases [RD-ACTION]
Rare diseases (RD) have been identified as one of the paradigmatic fields in which actions conducted at the European level constitute the adequate response to their specific problems: poor recognition...
Rare diseases (RD) have been identified as one of the paradigmatic fields in which actions conducted at the European level constitute the adequate response to their specific problems: poor recognition leading to diagnostic delay and inappropriate management including adapted social services, poor health outcomes, social burden, limited knowledge on natural history and pathophysiology leading to an insufficient development of new therapies. The low prevalence and the specificity of RD make that a global, multi-stakeholder approach, intended to gather specific expertise and to build shared strategies is necessary to address these issues.
The general objectives of RD-Action are to:
▪ Support the further development and sustainability of the Orphanet database, the biggest global repository of information on RD
▪ Contribute to solutions to ensure an appropriate codification of RD in health information systems
▪ Continue implementation of the priorities identified in Council Recommendation 2009/C151/02 and the Commission Communication (COM 2008 679) on RD, with a view to ensuring the sustainability of the recommended priority actions and to support the work of the Commission Expert Group on Rare Diseases (CEGRD).
This JA will expand and consolidate the achievements of the former JAs on RD supported by the European Commission: the Orphanet JA and the EUCERD JA. More precisely, this proposal has the ambition to help member states to implement the recommended measures adopted or to be adopted by the CEGRD and to produce the data necessary for countries to do so. Interactions between the production of data at the Orphanet database level and the implementation of policy priorities including codification will be strengthened during this JA.RD-Action large geographical coverage is key to success as it will promote the transfer of European recommendations into national policies and the collection of information and concerns from MS to the CEGRD, thus to the European Commission.

Start date: 01/06/2015 - End date: 31/07/2018

Call: Grants for actions co-financed with Member State authorities 2014 (Joint Actions)
Topic: Secondary care
First Programme of Community action in the field of public health (2003-2008)
European Haemophilia Safety Surveillance System [EUHASS]
The European Haemophilia Safety Surveillance (EUHASS) project aims to establish a pharmacovigilance program to monitor the safety of treatments for people with haemophilia. In addition it will develop...
The European Haemophilia Safety Surveillance (EUHASS) project aims to establish a pharmacovigilance program to monitor the safety of treatments for people with haemophilia. In addition it will develop and maintain a database of all the Haemophilia centres in Europe and establish a Rapid Alert System for immediate Europe-wide notification in case of unexpected or serious adverse events.
Start date: 01/10/2008 - End date: 01/10/2011

Call: Health Information (Hi 2007)
Topic: Secondary care
Second Programme of Community action in the Field of Health 2008-2013
22nd Alzheimer Europe Conference: Changing perceptions, practice and policy [22 AEC]
The Commission Communication on a European initiative on Alzheimer`s disease ingled out four main areas for greater EU collaboration:
1. Acting early to diagnose dementia,
2. A shared European effort ...
The Commission Communication on a European initiative on Alzheimer`s disease ingled out four main areas for greater EU collaboration:
1. Acting early to diagnose dementia,
2. A shared European effort in research,
3. National solidarity and exchange of best care practices,
4. Respecting the rights of people with dementia.

In order to support the actions outlined in the Commission Communication on a European initiative on Alzheimer`s disease and other dementias, the 22nd AE Conference will focus on these four priorities and organise an exchange of information, experiences, projects and best practices in the following areas:
1. Medical and scientific update (early diagnosis, prevention, epidemiology)
2. Social and care aspects (psycho-social interventions, care services, stigma and discrimination, integration of Alzheimer`s disease in mental health promotion activities)
3. Legal and ethical issues (guardianship systems, consent, advance directives, patients` rights)
4. Dementia strategies and policies (public health impact of dementia, national plans, financing of care, carer support measures, image of dementia).

In all areas, AE will identify key note speakers to provide state of the art presentations on the current knowledge and understanding, whilst inviting presenters to submit abstracts on ongoing and recently finalised research, projects and experiences.

In addition, AE will collaborate with EU funded initiatives to share the progress and results of research initiatives of programmes and projects like the Joint Programming Initiative on Neurodegenerative Disease, the Joint Action (ALCOVE-Alzheimer COoperation and Valuation in Europe), projects supported under the FP7 and AAL Programmes and by the Innovative Medicines Initiative (PharmaCog).


Start date: 04/10/2012 - End date: 04/10/2013

Call: Generate And Disseminate Health Information And Knowledge (Hi-2010)
Topic: Secondary care